fen phen,information,lawyer,attorney

American Home Products Corp. said Friday a Texas jury has awarded a woman $56.5 million for heart damage she claimed was caused by two company diet drugs once used in the "fen-phen" weight-loss cocktail.

click here to read

The Food and Drug Administration has asked manufacturers to voluntarily withdraw both fenfluramine and dexfenfluramine from the market…

click here to read 

News Articles dealing with fen-phen issues and judgements as they appear in USA Today.

click here to read

For more
Fen Phen information, visit fen phen

Fen Phen News - PPH Information

Fen Phen NEWs

is a resource that provides valuable information on PPH and the recall of fen phen.

Fen-phen is the common name for the combination of the drugs pondimin (fenfluramine), redux (dexfenfluramine) and phentermine. Several years ago, the diet industry widely marketed the drug as a "miracle cure" for weight loss. In July of 1997, the FDA requested that the drug, and dangerous derivations of fen-phen, be recalled from the market. Although fenfluramine and dexfenfluramine are no longer marketed in the U.S., individuals that took fen-phen may just now be experiencing medical conditions associated with the drug, including a serious and potentially fatal condition call primary pulmonary hypertension (PPH).

Since the fen phen recall numerous individual and class action lawsuits began to be filed throughout the entire country due to the deaths and serious cardiovascular conditions that were the direct result of fen phen use. Evidence that fen phen manufacturer, American Home Products, was aware of the potential fen phen risks well before the recall began to surface. By the time fen phen was pulled off the shelves an estimated 6 million to 7 million people in the U.S. had taken the diet drug.

As of January 3, 2002 the Nationwide Class Action Settlement Agreement with American Home Products Corporation received Final Judicial Approval, allowing anyone who has sustained injuries and health complications from fen phen to collect their claims.

For more information regarding PPH lawsuits, please contact us.

Fen Phen and PPH Information

Dr. Michael Weintraub developed fen phen while working as a researcher at the University of Rochester for the short-term management of obesity.

read the full story . . .


PPH Symptoms
Initial symptoms of PPH may be very minor, and diagnosis can be delayed for several years until symptoms worsen.

Patients suffering from Primary Pulmonary Hypertension (PPH) caused by Fen-Phen are NOT involved in the Nationwide Class Action Settlement Agreement with American Home Products. PPH patients must file independent lawsuits to make legal claims. To learn your legal rights, please contact us and speak with a PPH Lawyer for lawsuit information!

PPH Lawyer

American Home Products (AHP) withdrew fen phen from the U.S. market on September 15, 1997. Fen phen experienced immediate success after its introduction with 18,000,000 prescriptions written in 1996 alone. It has been estimated that between 6 million and 7 million people took fen phen in the U.S. prior to the FDA withdrawal.

Fen phen was associated to a serious and fatal condition called primary pulmonary hypertension (PPH), but the numerous fen phen supporters did not want to hear about the possible risks that involved fen phen with the successful weight loss that people were experiencing.

read the full story . . .

Fen Phen Recall

FDA Withdrawal of Fenfluramine and Dexfenfluramine (Fen Phen) Announcement

September 15, 1997


The Food and Drug Administration, acting on new evidence about significant side effects associated with fenfluramine and dexfenfluramine, has asked the manufacturers to voluntarily withdraw both treatments for obesity from the market. Dexfenfluramine is manufactured for Interneuron Pharmaceuticals and marketed under the name of Redux by Wyeth-Ayerst Laboratories, a subsidiary of American Home Products Corp. of Madison, N.J., which also manufactures and markets fenfluramine under the brand name Pondimin. Both companies have agreed to voluntarily withdraw their drugs. The FDA is not requesting the withdrawal of phentermine, the third widely used medication for obesity.

read the full story . . .

Fen Phen Information :: Primary Pulmonary Hypertension :: Fen Phen Lawyer Information
Dangers of Fen Phen
:: Fen Phen Recall :: Fen Phen Links :: Contact a PPH Lawyer :: Site Map